These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2317786)

  • 21. 17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell lines.
    Huynh PN; Carter WH; Loria RM
    Cancer Detect Prev; 2000; 24(5):435-44. PubMed ID: 11129985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells.
    Hurnanen D; Chan HM; Kubow S
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1520-8. PubMed ID: 9400029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB; Miron P; Miron A; Iglehart JD
    J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization.
    Wang Y; He QY; Chen H; Chiu JF
    Exp Cell Res; 2007 Jan; 313(2):357-68. PubMed ID: 17098229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
    Widschwendter M; Daxenbichler G; Dapunt O; Marth C
    Cancer Res; 1995 May; 55(10):2135-9. PubMed ID: 7743514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells.
    Jing Y; Waxman S; Mira-y-Lopez R
    Cancer Res; 1997 May; 57(9):1668-72. PubMed ID: 9135005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH; Stanslas J; Din LB
    Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
    Mueck AO; Seeger H; Wallwiener D
    Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells.
    Yuri T; Tsukamoto R; Miki K; Uehara N; Matsuoka Y; Tsubura A
    Oncol Rep; 2006 Dec; 16(6):1307-12. PubMed ID: 17089054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of cellular E-cadherin precedes replenishment of estrogen receptor and estrogen-dependent proliferation of breast cancer cells rescued from a death stimulus.
    Malaguti C; Rossini GP
    J Cell Physiol; 2002 Aug; 192(2):171-81. PubMed ID: 12115723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition.
    Lotan R
    Cancer Res; 1979 Mar; 39(3):1014-9. PubMed ID: 427741
    [No Abstract]   [Full Text] [Related]  

  • 37. Differences in uptake and metabolism of retinoic acid between estrogen receptor-positive and -negative human breast cancer cells.
    Okamoto K; Andreola F; Chiantore MV; Dedrick RL; De Luca LM
    Cancer Chemother Pharmacol; 2000; 46(2):128-34. PubMed ID: 10972482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition of estrogen receptor-positive human breast carcinoma cell growth by retinoic acid].
    Shao Z; Yu L; Jiang M
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):245-8. PubMed ID: 11038749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of retinoic acid on plasminogen activator activity and cellular proliferation.
    Tautt J; Mazur N; Koziorowska J
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):223-7. PubMed ID: 2102656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoic acid in MCF-7 human breast cancer cells.
    Lu Y; Wang X; Safe S
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):1-8. PubMed ID: 8048042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.